<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Dr. Adit Ginde, who’s researching monoclonal antibodies at the University of Colorado School of Medicine, says awareness is a major problem. “Patients in the general public haven’t generally heard of this treatment.”